Cellular and physiological functions of C9ORF72 and implications for ALS/FTD - Pang - 2021 - Journal of Neurochemistry - Wiley Online Library
Identified two drug targets for the diseases amyotrophic lateral sclerosis ( ALS) and frontotemporal dementia (FTD) - https://debuglies.com
Biomedicines | Free Full-Text | Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
Genes | Free Full-Text | Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
Frontotemporal Cognitive and Behavior Syndromes in ALS
Dysregulated molecular pathways in amyotrophic lateral sclerosis–frontotemporal dementia spectrum disorder | The EMBO Journal
Frontiers | Moving Toward Patient-Tailored Treatment in ALS and FTD: The Potential of Genomic Assessment as a Tool for Biological Discovery and Trial Recruitment
Grey and White Matter Changes across the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Continuum | PLOS ONE
Frontiers | Pathogenesis of Frontotemporal Lobar Degeneration: Insights From Loss of Function Theory and Early Involvement of the Caudate Nucleus
PDF) A case of Progressive Non-Fluent Aphasia as onset of Amyotrophic Lateral Sclerosis with FrontoTemporal Dementia
Insight in ALS: Awareness of behavioral change in patients with and without FTD: Amyotrophic Lateral Sclerosis: Vol 11, No 1-2
Recent Advances in Frontotemporal Dementia | ACNR Journal
Frontotemporal Dementia and ALS in daily Practice: Red Flags Professor Sharon Abrahams, University of Edinburgh Overviews Golds
From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline | Molecular Neurodegeneration | Full Text
Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia | Molecular Neurobiology
Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Neuron
Grey and White Matter Changes across the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Continuum | PLOS ONE
From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline | Molecular Neurodegeneration | Full Text
Symptomatic ALS and FTD Have Different Patterns of Neuroinflammation
New genetic therapy shows promise for motor neuron disease and frontotemporal dementia
Dysregulated molecular pathways in amyotrophic lateral sclerosis–frontotemporal dementia spectrum disorder | The EMBO Journal
Diagnostics | Free Full-Text | Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degenerations: Similarities in Genetic Background
IJMS | Free Full-Text | Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
Recent Advances in Frontotemporal Dementia | Canadian Journal of Neurological Sciences | Cambridge Core
